Hypercalcemia in children induced by denosumab: a case report and an analysis of the FDA adverse event reporting system database

The potential risks of denosumab on pediatric patients have raised concerns about its safety. This article aims to analyze the adverse effects of denosumab in minors, with a specific focus on hypercalcemia.